Cargando…

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy

Prostate cancer antigen 3 (PCA3) is a biomarker for diagnosing prostate cancer (PCa) identified in the Caucasian population. We evaluated the effectiveness of urinary PCA3 in predicting the biopsy result in 500 men undergoing initial prostate biopsy. The predictive power of the PCA3 score was evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fu-Bo, Chen, Rui, Ren, Shan-Cheng, Shi, Xiao-Lei, Zhu, Ya-Sheng, Zhang, Wei, Jing, Tai-Le, Zhang, Chao, Gao, Xu, Hou, Jian-Guo, Xu, Chuan-Liang, Sun, Ying-Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312226/ https://www.ncbi.nlm.nih.gov/pubmed/26780868 http://dx.doi.org/10.4103/1008-682X.167715

Ejemplares similares

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy
por: Zhang, Xuefeng, et al.
Publicado: (2017)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
por: Sakamoto, Yoshiro, et al.
Publicado: (2014)

Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy
por: Zhou, Yi, et al.
Publicado: (2018)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy
por: Zhou, Chenchao, et al.
Publicado: (2017)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

PCA3 and PCA3-Based Nomograms Improve Diagnostic Accuracy in Patients Undergoing First Prostate Biopsy
por: Ruffion, Alain, et al.
Publicado: (2013)

A systematic review of the diagnostic accuracy of prostate specific antigen
por: Harvey, Philip, et al.
Publicado: (2009)

Combination of PI-RADS score and PSAD can improve the diagnostic accuracy of prostate cancer and reduce unnecessary prostate biopsies
por: Wang, Changming, et al.
Publicado: (2022)

Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population
por: Na, Rong, et al.
Publicado: (2013)

Consistency and diagnostic accuracy of 4 assays in the detection of the total and free prostate-specific antigen
por: Deng, Lingyan, et al.
Publicado: (2023)

Accuracy of a High Prostate-Specific Antigen Level for Prostate Cancer Diagnosis upon Initial Biopsy in Korean Men
por: Shim, Hong Bang, et al.
Publicado: (2007)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

New model of PIRADS and adjusted prostate-specific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study
por: Huang, Chen, et al.
Publicado: (2022)

Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020)

Prostate biopsy for elevated prostate specific antigen (PSA) – Indian perspective
por: Ragavan, N.
Publicado: (2014)

Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer
por: Wang, Xijuan, et al.
Publicado: (2017)

The Prostate Cancer Detection Rate on the Second Prostate Biopsy according to Prostate-Specific Antigen Trend
por: Kim, Hyung-Sang, et al.
Publicado: (2012)

The Influence of Serum Prostate-Specific Antigen on the Accuracy of Magnetic Resonance Imaging Targeted Biopsy versus Saturation Biopsy in Patients with Previous Negative Biopsy
por: Chang, Chao-Hsiang, et al.
Publicado: (2017)

An overview of serum prostatic surface antigen cut points for recommendation of prostatic biopsy
por: Patwardhan, Sujata K., et al.
Publicado: (2018)

Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy
por: Xie, Gan-Sheng, et al.
Publicado: (2016)

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy
por: Simmons, Lucy A M, et al.
Publicado: (2017)

Diagnostic accuracy and clinical utility of micro-ultrasound guided biopsies in patients with suspected prostate cancer
por: Dias, Nuno, et al.
Publicado: (2023)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
por: Merriel, Samuel W. D., et al.
Publicado: (2022)

The Diagnostic Accuracy of Prostate-Specific Antigen and Digital Rectal Examination in the Diagnosis of Prostate Cancer at the University of Benin Teaching Hospital
por: Ozah, Ehiremhen, et al.
Publicado: (2023)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

Comparisons of the diagnostic accuracy across prostate health index, prostate health index density, and percentage free prostate-specific antigen for clinically significant prostate cancer: a prospective diagnostic study
por: Wu, Bo, et al.
Publicado: (2023)

Is Prostate Biopsy Essential to Diagnose Prostate Cancer in the Older Patient with Extremely High Prostate-Specific Antigen?
por: Jang, Jee Young, et al.
Publicado: (2012)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
por: Park, Yong Hyun, et al.
Publicado: (2014)

Can Prostate-Specific Antigen Kinetics before Prostate Biopsy Predict the Malignant Potential of Prostate Cancer?
por: Kim, Sang Jin, et al.
Publicado: (2015)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Diagnostic accuracy of urinary prostate protein glycosylation profiling in prostatitis diagnosis
por: Vermassen, Tijl, et al.
Publicado: (2015)

COMPARISON OF GRADING ACCURACY OF PROSTATE CANCER IN SAMPLES ACQUIRED BY A TARGETED AND SYSTEMIC PROSTATE BIOPSY
por: Pezelj, Ivan, et al.
Publicado: (2022)

The predictive efficacy of hypoechoic lesion in ultrasound for prostate cancer in Chinese people: five-year experience in a moderated 10-core transperineal prostate biopsy procedure
por: Yang, Tian, et al.
Publicado: (2017)

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population
por: Wei, Han-Min, et al.
Publicado: (2015)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Prostate-specific antigen testing accuracy in community practice
por: Hoffman, Richard M, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ia0gpjv4e7j1e3gn8cvabd6dcb